Preventive and therapeutic applications of neutralizing antibodies to Human Immunodeficiency Virus Type 1 (HIV-1).

about

Broadly neutralizing antibodies in HIV-1 treatment and prevention

P2860

Q57815702-BFBCF9A4-D4DD-4EF3-B5BF-4C92A5328EED

P2860

Preventive and therapeutic applications of neutralizing antibodies to Human Immunodeficiency Virus Type 1 (HIV-1).

Item

http://www.wikidata.org/entity/Q38206519

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Preventive and therapeutic app ...... ficiency Virus Type 1 (HIV-1).

@en

type

Item

label

Preventive and therapeutic app ...... ficiency Virus Type 1 (HIV-1).

@en

prefLabel

Preventive and therapeutic app ...... ficiency Virus Type 1 (HIV-1).

@en

P1476

Preventive and therapeutic app ...... ficiency Virus Type 1 (HIV-1).

@en

P2093

Jayanta Bhattacharya

http://www.w3.org/2001/XMLSchema#string

Rajesh Ringe

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody vs. HIV in a clash of evolutionary titans

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1

A Blueprint for HIV Vaccine Discovery

A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

Crystal Structure of the Neutralizing Llama VHH D7 and Its Mode of HIV-1 gp120 Interaction

Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

P304

67-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2051013613494534

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24757516

http://www.w3.org/2001/XMLSchema#string

P932

3967664

http://www.w3.org/2001/XMLSchema#string

Preventive and therapeutic applications of neutralizing antibodies to Human Immunodeficiency Virus Type 1 (HIV-1).

about

P2860

P2860

Preventive and therapeutic applications of neutralizing antibodies to Human Immunodeficiency Virus Type 1 (HIV-1).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932